 Proteomics
"Proteomics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The systematic study of the complete complement of proteins (PROTEOME) of organisms.
| Descriptor ID |
D040901
|
| MeSH Number(s) |
H01.158.201.843 H01.158.273.180.350.700 H01.158.273.343.350.700 H01.181.122.738
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteomics".
Below are MeSH descriptors whose meaning is more specific than "Proteomics".
This graph shows the total number of publications written about "Proteomics" by people in this website by year, and whether "Proteomics" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 | | 2003 | 3 | 3 | 6 | | 2004 | 10 | 1 | 11 | | 2005 | 7 | 2 | 9 | | 2006 | 12 | 8 | 20 | | 2007 | 4 | 4 | 8 | | 2008 | 10 | 7 | 17 | | 2009 | 13 | 8 | 21 | | 2010 | 21 | 7 | 28 | | 2011 | 18 | 15 | 33 | | 2012 | 18 | 18 | 36 | | 2013 | 4 | 16 | 20 | | 2014 | 16 | 15 | 31 | | 2015 | 8 | 12 | 20 | | 2016 | 13 | 12 | 25 | | 2017 | 10 | 11 | 21 | | 2018 | 12 | 18 | 30 | | 2019 | 10 | 14 | 24 | | 2020 | 11 | 16 | 27 | | 2021 | 6 | 22 | 28 | | 2022 | 8 | 21 | 29 | | 2023 | 5 | 26 | 31 | | 2024 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Proteomics" by people in Profiles.
-
Kim YK, Kim YR, Wells KL, Sarbaugh D, Guney M, Tsai CF, Zee T, Karsenty G, Nakayasu ES, Sussel L. PTPN2 Regulates Metabolic Flux to Affect ?-Cell Susceptibility to Inflammatory Stress. Diabetes. 2024 Mar 01; 73(3):434-447.
-
Suryadevara R, Gregory A, Lu R, Xu Z, Masoomi A, Lutz SM, Berman S, Yun JH, Saferali A, Ryu MH, Moll M, Sin DD, Hersh CP, Silverman EK, Dy J, Pratte KA, Bowler RP, Castaldi PJ, Boueiz A. Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema. Am J Respir Crit Care Med. 2024 02 01; 209(3):273-287.
-
He F, Laranjeira AB, Kong T, Lin S, Ashworth KJ, Liu A, Lasky NM, Fisher DA, Cox MJ, Fulbright MC, Antunes-Heck L, Yu L, Brakhane M, Gao B, Sykes SM, D'Alessandro A, Di Paola J, Oh ST. Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms. J Clin Invest. 2024 Feb 01; 134(3).
-
Kant R, Mishra N, Kandhari K, Saba L, Michel C, Reisdorph R, Tewari-Singh N, Pantcheva MB, Petrash JM, Agarwal C, Agarwal R. Dexamethasone targets actin cytoskeleton signaling and inflammatory mediators to reverse sulfur mustard-induced toxicity in rabbit corneas. Toxicol Appl Pharmacol. 2024 02; 483:116834.
-
Leggere JC, Hibbard JVK, Papoulas O, Lee C, Pearson CG, Marcotte EM, Wallingford JB. Label-free proteomic comparison reveals ciliary and nonciliary phenotypes of IFT-A mutants. Mol Biol Cell. 2024 Mar 01; 35(3):ar39.
-
van Doormaal PTC, Thomas S, Ajroud-Driss S, Cole RN, DeVine LR, Dimachkie MM, Geisler S, Freeman R, Simpson DM, Singleton JR, Smith AG, Stino A, H?ke A. Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients. J Peripher Nerv Syst. 2024 Mar; 29(1):88-96.
-
Stincone P, Naimi A, Saviola AJ, Reher R, Petras D. Decoding the molecular interplay in the central dogma: An overview of mass spectrometry-based methods to investigate protein-metabolite interactions. Proteomics. 2024 Jun; 24(12-13):e2200533.
-
Tesfaigzi Y, Curtis JL, Petrache I, Polverino F, Kheradmand F, Adcock IM, Rennard SI. Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types? Am J Respir Cell Mol Biol. 2023 11; 69(5):500-507.
-
Mishra N, Kant R, Goswami DG, Petrash JM, Agarwal C, Tewari-Singh N, Agarwal R. Metabolomics for identifying pathways involved in vesicating agent lewisite-induced corneal injury. Exp Eye Res. 2023 11; 236:109672.
-
Frank BS, Nandy D, Khailova L, Mitchell MB, Morgan GJ, Twite M, DiMaria MV, Davidson JA. Circulating biomarkers of extracellular matrix dysregulation are associated with adverse post-stage 2 outcomes in infants with single ventricle heart disease. Sci Rep. 2023 09 28; 13(1):16318.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|